Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Seth B Furgeson

TitlePrincipal Investigator
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Research 
    Collapse research activities and funding
    K08HL103774     (FURGESON, SETH BERNAT)Apr 18, 2011 - Mar 31, 2016
    The role of smooth muscle PPAR gamma in neointima formation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Montford JR, Furgeson SB. A new CTGF target in renal fibrosis. Kidney Int. 2017 Oct; 92(4):784-786. PMID: 28938948.
      View in: PubMed
    2. Ranjit S, Dobrinskikh E, Montford J, Dvornikov A, Lehman A, Orlicky DJ, Nemenoff R, Gratton E, Levi M, Furgeson S. Label-free fluorescence lifetime and second harmonic generation imaging microscopy improves quantification of experimental renal fibrosis. Kidney Int. 2016 Nov; 90(5):1123-1128. PMID: 27555119.
      View in: PubMed
    3. Montford JR, Lehman AM, Scobey MS, Weiser-Evans MC, Nemenoff RA, Furgeson SB. Cytosolic phospholipase A2a increases proliferation and de-differentiation of human renal tubular epithelial cells. Prostaglandins Other Lipid Mediat. 2016 Nov; 126:1-8. PMID: 27554058.
      View in: PubMed
    4. Lehman AM, Montford JR, Horita H, Ostriker AC, Weiser-Evans MC, Nemenoff RA, Furgeson SB. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells. Mol Pharmacol. 2014 Nov; 86(5):570-9. PMID: 25169989; PMCID: PMC4201143.
    5. Horita H, Furgeson SB, Ostriker A, Olszewski KA, Sullivan T, Villegas LR, Levine M, Parr JE, Cool CD, Nemenoff RA, Weiser-Evans MC. Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension. J Am Heart Assoc. 2013 May 31; 2(3):e000188. PMID: 23727701; PMCID: PMC3698782.
    6. Furgeson SB, Teitelbaum I. Basically, dialysis is not good enough. Clin J Am Soc Nephrol. 2013 Feb; 8(2):177-8. PMID: 23307877.
      View in: PubMed
    7. Horita HN, Simpson PA, Ostriker A, Furgeson S, Van Putten V, Weiser-Evans MC, Nemenoff RA. Serum response factor regulates expression of phosphatase and tensin homolog through a microRNA network in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011 Dec; 31(12):2909-19. PMID: 21940949; PMCID: PMC3220738.
    8. Nemenoff RA, Horita H, Ostriker AC, Furgeson SB, Simpson PA, VanPutten V, Crossno J, Offermanns S, Weiser-Evans MC. SDF-1a induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2011 Jun; 31(6):1300-8. PMID: 21415388; PMCID: PMC3111081.
    9. Furgeson SB, Linas S. Mechanisms of type I and type II pseudohypoaldosteronism. J Am Soc Nephrol. 2010 Nov; 21(11):1842-5. PMID: 20829405.
      View in: PubMed
    10. Furgeson SB, Simpson PA, Park I, Vanputten V, Horita H, Kontos CD, Nemenoff RA, Weiser-Evans MC. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res. 2010 May 01; 86(2):274-82. PMID: 20051384; PMCID: PMC2856191.
    11. Furgeson SB, Teitelbaum I. New treatment options and protocols for peritoneal dialysis-related peritonitis. Contrib Nephrol. 2009; 163:169-76. PMID: 19494611.
      View in: PubMed
    12. Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, Cooper J, Weiser-Evans MC. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res. 2008 May 09; 102(9):1036-45. PMID: 18340011.
      View in: PubMed
    13. Furgeson SB, Chonchol M. Beta-blockade in chronic dialysis patients. Semin Dial. 2008 Jan-Feb; 21(1):43-8. PMID: 18251957.
      View in: PubMed
    14. Gonzalez OY, Musher DM, Brar I, Furgeson S, Boktour MR, Septimus EJ, Hamill RJ, Graviss EA. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003 Jan 15; 36(2):140-8. PMID: 12522745.
      View in: PubMed
    Furgeson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)